Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Offices
  4. /
  5. Minneapolis District Office
FDA Office
•USA

Minneapolis District Office

View detailed information about Minneapolis District Office, including compliance records, people, and regulatory data.

Sign in to open in Dashboard
Office Profile

Comprehensive profile of Minneapolis District Office, including its role, location, and regulatory activities.

Records (20)
WARNING_LETTER - CocoKefir LLC

Drugs • November 22, 2011

WARNING_LETTER
WARNING_LETTER - Wellness Resources, Inc.

Drugs • November 30, 2017

WARNING_LETTER
483 - University of Wisconsin System Radiopharmaceutical Production Facility

drugs • Unknown Date

483
483 - Wisconsin Medical Radiopharmacy, LLC.

drugs • Unknown Date

483
WARNING_LETTER - Drs. Foster and Smith, Inc.

Drugs • September 5, 2008

WARNING_LETTER
483 - PPD Development, L.P.

drugs • March 3, 2017

483
WARNING_LETTER - Premium Gold Flax Products & Processing Inc.

Drugs • July 1, 2011

WARNING_LETTER
WARNING_LETTER - CAW Industries, Inc.

January 31, 2012

WARNING_LETTER
483 - MPP GROUP, LLC

drugs • Unknown Date

483
483 - Scientific Protein Laboratories, LLC

drugs • Unknown Date

483
WARNING_LETTER - Wisconsin Aluminum Foundry Co

Devices • May 12, 2011

WARNING_LETTER
WARNING_LETTER - Cardio Renew Inc

Drugs • October 12, 2010

WARNING_LETTER
483 - Eurofins Food Chemistry Testing Madison, Inc.

drugs • Unknown Date

483
483 - Kingchem Laboratories Inc.

drugs • October 20, 2017

483
483 - Isomedix Operations Inc.

other • Unknown Date

483
WARNING_LETTER - Rahm Dairy LLC

Drugs • November 19, 2015

WARNING_LETTER
483 - ANI Pharmaceuticals, Inc.

drugs • Unknown Date

483
WARNING_LETTER - Upsher Smith Laboratories, Inc.

Drugs • January 19, 2011

WARNING_LETTER
WARNING_LETTER - Schwabe North America, Inc.

Drugs • February 15, 2012

WARNING_LETTER
483 - Noble Pharma, LLC

drugs • March 6, 2025

483

Showing 1 to 20 of 20 records

Related Offices (5)
Office of Compliance Intervention and Consultation
OCIC
Acting Division Director
Bureau of Environmental Health
Division of Nonprescription Drug Products
Division of Reproductive and Urologic Products
Office Information

Name

Minneapolis District Office

Abbreviation

MIN-DO

Country

USA

Postal Code

55401

State/Province

Minnesota

City

Minneapolis

Address

250 Marquette Avenue, Suite 600

ID: c79fc8dc-f884-48fc-ba80-2947f662511d

Get More Insights

Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more offices? Our platform provides access to hundreds of FDA offices with advanced search and filtering capabilities.

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.